ProfileGDS4718 / 213544_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 16% 17% 12% 10% 15% 23% 19% 16% 14% 9% 10% 20% 17% 22% 20% 8% 12% 16% 18% 19% 5% 13% 14% 15% 12% 21% 11% 11% 11% 18% 18% 12% 15% 9% 12% 15% 11% 17% 11% 11% 12% 20% 12% 14% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.998416
GSM549102patient 115, normal, homogenized [OPG study]4.0364717
GSM549104patient 119, normal, homogenized [OPG study]3.8476112
GSM549108patient 138, normal, homogenized [OPG study]3.8063510
GSM549119patient 077, normal, homogenized [OPG study]3.9688915
GSM549133patient 032, cancer, homogenized [OPG study]4.2226923
GSM549139patient 042, cancer, homogenized [OPG study]4.0965819
GSM549099patient 107, normal, homogenized [OPG study]3.9942416
GSM549109patient 139, normal, homogenized [OPG study]3.9670514
GSM549110patient 046, normal, homogenized [OPG study]3.761889
GSM549114patient 063, normal, homogenized [OPG study]3.7556310
GSM549122patient 082, normal, homogenized [OPG study]4.1681620
GSM549134patient 033, cancer, homogenized [OPG study]4.0353517
GSM549136patient 036, cancer, homogenized [OPG study]4.1748122
GSM549140patient 044, cancer, homogenized [OPG study]4.0923820
GSM549111patient 047, normal, homogenized [OPG study]3.690188
GSM549113patient 057, normal, homogenized [OPG study]3.8238712
GSM549132patient 031, cancer, homogenized [OPG study]3.990416
GSM549137patient 038, cancer, homogenized [OPG study]4.0712318
GSM549142patient 047, cancer, homogenized [OPG study]4.2075819
GSM549100patient 110, normal, homogenized [OPG study]3.566415
GSM549107patient 135, normal, homogenized [OPG study]3.8577713
GSM549115patient 068, normal, homogenized [OPG study]3.8818714
GSM549116patient 072, normal, homogenized [OPG study]3.9403615
GSM549120patient 078, normal, homogenized [OPG study]3.8439412
GSM549131patient 030, cancer, homogenized [OPG study]4.1230121
GSM549118patient 074, normal, homogenized [OPG study]3.8120711
GSM549129patient 027, cancer, homogenized [OPG study]3.8191711
GSM549123patient 088, normal, homogenized [OPG study]3.8287611
GSM549124patient 006, cancer, homogenized [OPG study]4.0989218
GSM549126patient 015, cancer, homogenized [OPG study]4.0708218
GSM549128patient 025, cancer, homogenized [OPG study]3.8194912
GSM549103patient 117, normal, homogenized [OPG study]3.9863215
GSM549117patient 073, normal, homogenized [OPG study]3.736829
GSM549138patient 041, cancer, homogenized [OPG study]3.8258412
GSM549141patient 045, cancer, homogenized [OPG study]3.9147415
GSM549130patient 028, cancer, homogenized [OPG study]3.8328211
GSM549101patient 111, normal, homogenized [OPG study]4.0469417
GSM549105patient 128, normal, homogenized [OPG study]3.8367611
GSM549106patient 134, normal, homogenized [OPG study]3.771611
GSM549112patient 048, normal, homogenized [OPG study]3.8519412
GSM549125patient 011, cancer, homogenized [OPG study]4.1478520
GSM549127patient 024, cancer, homogenized [OPG study]3.8228312
GSM549135patient 035, cancer, homogenized [OPG study]3.8861614